← Back to Search

Family Perspective Program for Respiratory Failure

N/A
Recruiting
Led By Matthew Modes, MD, MPP, MS
Research Sponsored by Matthew Modes
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
o Individuals 18 years old or older.
Individuals with acute respiratory failure, defined as >24 hours of invasive mechanical ventilation.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial aims to test a program that helps families of seriously ill patients communicate better and receive emotional support. The study will involve collecting information from medical charts, surveys, and meetings with counselors and doctors.

Who is the study for?
This trial is for adults over 18 in the MICU at Cedars-Sinai with acute respiratory failure needing a ventilator for more than 24 hours. It includes their primary decision-makers and ICU staff. Participants must speak English. Those not expected to need extended ventilation or unable to consent are excluded.Check my eligibility
What is being tested?
The Family Perspectives Program aims to improve communication and support between families of critically ill patients, ICU counselors, and care teams through meetings, questionnaires, optional audio recordings of discussions, and interviews.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this study as it involves non-medical interventions like enhanced communication procedures rather than drugs or medical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been on a breathing machine for more than 24 hours.
Select...
I was put on a breathing machine within 24 hours of being admitted to the intensive care unit.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of implementing the program for families of patients with acute respiratory failure.
Secondary outcome measures
Feasibility of collecting data from ICU care team members
Feasibility of collecting data from ICU support counselors
Feasibility of collecting data from families
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Family Perspective ProgramExperimental Treatment1 Intervention
Families of critically ill patients will receive a program designed to enhance equitable communication and emotional support. Questionnaires will be completed by primary surrogate decision makers, ICU support counselors, and ICU care team members (physicians, nurses, social workers). Meetings between families and ICU support counselors will be audio recorded (optional). Meetings between families and ICU care teams will be audio recorded (optional). Interviews with participants will be completed (optional).
Group II: Usual CareActive Control1 Intervention
Families of critically ill patients will receive usual care, which involves regular and routine meetings between families and the ICU care team. Questionnaires will be completed by primary surrogate decision makers and ICU care team members (physicians, nurses, social workers). Meetings between families and ICU care teams will be audio recorded (optional). Interviews with participants will be completed (optional).

Find a Location

Who is running the clinical trial?

Matthew ModesLead Sponsor
Icahn School of Medicine at Mount SinaiOTHER
861 Previous Clinical Trials
525,206 Total Patients Enrolled
Matthew Modes, MD, MPP, MSPrincipal InvestigatorCedars-Sinai Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process for this study currently ongoing?

"Indeed, the data available on clinicaltrials.gov confirms that this trial is actively seeking participants. The study was initially posted on October 13th, 2023 and last updated on January 19th, 2024. The trial aims to enroll a total of 70 patients from one specific location."

Answered by AI

How large is the participant pool in this medical study?

"Indeed, the information provided on clinicaltrials.gov indicates that this specific clinical trial is actively seeking eligible participants. The initial posting of the trial occurred on October 13th, 2023 and it was most recently updated on January 19th, 2024. In total, the study aims to enroll a cohort of 70 individuals at a single designated location."

Answered by AI
~32 spots leftby Oct 2024